As the scale of Pune’s Guillain-Barré Syndrome (GBS) outbreak grows, with the number of cases rising to 101, there is much curiosity around the prognosis and treatment of the rare condition.

MS develops over time and can ... No cure has been found yet for GBS. However, treatments can shorten recovery time and ... Bellanti R, et al. (2024). Guillain-Barre syndrome: A ...

Nitin Narain, a survivor of Guillain-Barre Syndrome (GBS), recounts his harrowing experience with the disease and his long road to recovery. Nitin Narain 1 Stories Wednesday February 05, 2025 , 6 ...

Multiple sclerosis (MS) and Guillain-Barré syndrome (GBS) are diseases of the nervous system. They’re not the same, but they do have a lot of similarities. Both MS and GBS are autoimmune ...

A 22-year-old youth recovered from Guillain-Barré Syndrome (GBS) after an 96-day stay in Nanded's Dr Shankarrao Chavan Gove.

Brian Dube of Acushnet, lead pastor at a New Bedford church, was diagnosed with Guillain-Barré syndrome. The disease is a rare neurological disorder and can be fatal, causing paralysis. Dube ...

Tingling, weakness of hand-grip or foot drop could signal Guillain-Barré Syndrome (GBS), said health experts on Monday, even as the reported cases spike in Pune ...

Guillain-Barré Syndrome (GBS) is an autoimmune neurological disorder in which a person’s immune system attacks their peripheral nerves, leading to muscle weakness that can progress to paralysis.

In the Phase 3 pivotal trial of 241 patients, tanruprubart met the primary endpoint with consistent outcomes and rapid, more complete functional recovery versus placebo across multiple time points ...

First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005 ...

Date/Time: Monday, May 19, from 3:55 pm to 4:10 pm British Summer Time (BST) Poster Presentations “Linking Early Complement Inhibition to Long-Term Outcomes in GBS: Objective Measures Support ...